575 related articles for article (PubMed ID: 34025638)
1. Bispecific Antibodies: From Research to Clinical Application.
Ma J; Mo Y; Tang M; Shen J; Qi Y; Zhao W; Huang Y; Xu Y; Qian C
Front Immunol; 2021; 12():626616. PubMed ID: 34025638
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin Gamma-Like Therapeutic Bispecific Antibody Formats for Tumor Therapy.
Chen S; Li L; Zhang F; Wang Y; Hu Y; Zhao L
J Immunol Res; 2019; 2019():4516041. PubMed ID: 30886871
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapeutic progress and application of bispecific antibody in cancer.
Kang J; Sun T; Zhang Y
Front Immunol; 2022; 13():1020003. PubMed ID: 36341333
[TBL] [Abstract][Full Text] [Related]
4. Bispecific antibodies.
Kontermann RE; Brinkmann U
Drug Discov Today; 2015 Jul; 20(7):838-47. PubMed ID: 25728220
[TBL] [Abstract][Full Text] [Related]
5. Antibody-drug conjugates and bispecific antibodies targeting cancers: applications of click chemistry.
Hong Y; Nam SM; Moon A
Arch Pharm Res; 2023 Mar; 46(3):131-148. PubMed ID: 36877356
[TBL] [Abstract][Full Text] [Related]
6. Bispecific antibodies: design, therapy, perspectives.
Sedykh SE; Prinz VV; Buneva VN; Nevinsky GA
Drug Des Devel Ther; 2018; 12():195-208. PubMed ID: 29403265
[TBL] [Abstract][Full Text] [Related]
7. Bispecific monoclonal antibodies for targeted immunotherapy of solid tumors: Recent advances and clinical trials.
Hosseini SS; Khalili S; Baradaran B; Bidar N; Shahbazi MA; Mosafer J; Hashemzaei M; Mokhtarzadeh A; Hamblin MR
Int J Biol Macromol; 2021 Jan; 167():1030-1047. PubMed ID: 33197478
[TBL] [Abstract][Full Text] [Related]
8. A review of bispecific antibodies and antibody constructs in oncology and clinical challenges.
Suurs FV; Lub-de Hooge MN; de Vries EGE; de Groot DJA
Pharmacol Ther; 2019 Sep; 201():103-119. PubMed ID: 31028837
[TBL] [Abstract][Full Text] [Related]
9. Current landscape and future directions of bispecific antibodies in cancer immunotherapy.
Wei J; Yang Y; Wang G; Liu M
Front Immunol; 2022; 13():1035276. PubMed ID: 36389699
[TBL] [Abstract][Full Text] [Related]
10. "BIClonals": Production of Bispecific Antibodies in IgG Format in Transiently Transfected Mammalian Cells.
Litvak-Greenfeld D; Vaks L; Dror S; Nahary L; Benhar I
Methods Mol Biol; 2019; 1904():431-454. PubMed ID: 30539485
[TBL] [Abstract][Full Text] [Related]
11. Bispecific antibodies and trispecific immunocytokines for targeting the immune system against cancer: preparing for the future.
Fournier P; Schirrmacher V
BioDrugs; 2013 Feb; 27(1):35-53. PubMed ID: 23329400
[TBL] [Abstract][Full Text] [Related]
12. A tale of two specificities: bispecific antibodies for therapeutic and diagnostic applications.
Byrne H; Conroy PJ; Whisstock JC; O'Kennedy RJ
Trends Biotechnol; 2013 Nov; 31(11):621-32. PubMed ID: 24094861
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor activity of stability-engineered IgG-like bispecific antibodies targeting TRAIL-R2 and LTbetaR.
Michaelson JS; Demarest SJ; Miller B; Amatucci A; Snyder WB; Wu X; Huang F; Phan S; Gao S; Doern A; Farrington GK; Lugovskoy A; Joseph I; Bailly V; Wang X; Garber E; Browning J; Glaser SM
MAbs; 2009; 1(2):128-41. PubMed ID: 20061822
[TBL] [Abstract][Full Text] [Related]
14. Bispecific antibodies targeting immunomodulatory checkpoints for cancer therapy.
Zhang T; Lin Y; Gao Q
Cancer Biol Med; 2023 Mar; 20(3):181-95. PubMed ID: 36971124
[TBL] [Abstract][Full Text] [Related]
15. Tumor-antigen-binding bispecific antibodies for cancer treatment.
Weidle UH; Kontermann RE; Brinkmann U
Semin Oncol; 2014 Oct; 41(5):653-60. PubMed ID: 25440609
[TBL] [Abstract][Full Text] [Related]
16. [Recent advances in the development of bispecific antibodies].
Ye J; Meng S; Zhu X
Sheng Wu Gong Cheng Xue Bao; 2020 Jan; 36(1):33-43. PubMed ID: 32072779
[TBL] [Abstract][Full Text] [Related]
17. Bispecific antibodies: a mechanistic review of the pipeline.
Labrijn AF; Janmaat ML; Reichert JM; Parren PWHI
Nat Rev Drug Discov; 2019 Aug; 18(8):585-608. PubMed ID: 31175342
[TBL] [Abstract][Full Text] [Related]
18. Computational design of a specific heavy chain/κ light chain interface for expressing fully IgG bispecific antibodies.
Froning KJ; Leaver-Fay A; Wu X; Phan S; Gao L; Huang F; Pustilnik A; Bacica M; Houlihan K; Chai Q; Fitchett JR; Hendle J; Kuhlman B; Demarest SJ
Protein Sci; 2017 Oct; 26(10):2021-2038. PubMed ID: 28726352
[TBL] [Abstract][Full Text] [Related]
19. Bispecific, T-Cell-Recruiting Antibodies in B-Cell Malignancies.
Lejeune M; Köse MC; Duray E; Einsele H; Beguin Y; Caers J
Front Immunol; 2020; 11():762. PubMed ID: 32457743
[TBL] [Abstract][Full Text] [Related]
20. Bioassay Development for Bispecific Antibodies-Challenges and Opportunities.
Register AC; Tarighat SS; Lee HY
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
